Paxis Pharmaceuticals manufactures and markets the generic active pharmaceutical ingredient (API) Paclitaxel. Paxis Pharmaceuticals is based in Boulder, Colorado and is a wholly owned subsidiary of Integrated BioPharma (INB:AMEX).

Paxis has established a strong asset base and is vertically integrated from the forest to the final API. Paxis has sound financial backing and is positioned to be the strongest supplier of taxane based pharmaceutical ingredients for many years to come.

Our Mission: To be the Premier Supplier of Paclitaxel API and other naturally derived taxanes to the Pharmaceutical Industry.
 
 
 
 
225 Long Avenue, Hillside, NJ 07205 USA
Tel 973.926.0816  Fax 973.926.1735
Investor Relations 888.319.6962